Srini Tenjarla

Insider Reports History

Entity
Individual
Location
601 Genome Way Suite 2001, Huntsville, AL
Signature
/s/ Srini Tenjarla
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Srini Tenjarla:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Serina Therapeutics, Inc. SVP, CMC & Formulation Stock Option (right to buy) 185K Jul 15, 2024 Direct

Insider Reports Filed by Srini Tenjarla

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SER Serina Therapeutics, Inc. Jul 15, 2024 1 $0 4 Jul 17, 2024 SVP, CMC & Formulation
SER Serina Therapeutics, Inc. Jul 15, 2024 0 $0 3 Jul 17, 2024 SVP, CMC & Formulation